The modulation on NMDARs-mediated Ca2+ influxes of PP2A and NR3A prompted us to advocate a hypothesis that both two regulatory factors could contribute to the protective mechanism of Simvastatin in ischemic stroke. The gene discussed is GRIN3A; the disease is ischemic stroke.